PMID- 28179312 OWN - NLM STAT- MEDLINE DCOM- 20170227 LR - 20170227 IS - 1791-7530 (Electronic) IS - 0250-7005 (Linking) VI - 37 IP - 2 DP - 2017 Feb TI - MDS/AML del(11)(q14) Share Common Morphological Features Despite Different Chromosomal Breakpoints. PG - 645-649 AB - In myelodysplatic syndromes and acute myeloid leukemia (MDS/AML) deletion of the 11q14 region is a rare chromosomal defect (incidence: 0.6-1.0%), included within the intermediate risk criteria by the International Prognostic Scoring System. No fluorescence in situ hybridization (FISH) study has yet been performed to identify a common breakpoint region (CBR). In our study through FISH with bacterial artificial chromosomes and commercial probes, we analyzed seven patients with MDS/AML harboring 11q14 deletion on conventional cytogenetic analysis. FISH revealed deletions in five patients and amplifications in two. Three patients with deletion carried a CBR, two had a deletion involving a more centromeric breakpoint. These five patients exhibited multilineage dysplasia, blast cells with large round nuclei, loose chromatin, small and abundant nucleoli, and vacuolated cytoplasm with very thin Auer bodies. In conclusion, the morphological features which occur independently of the extent of the deletion are of multilineage dysplasia in MDS and leukemic blasts strongly reactive to peroxidase in AML; despite the variable size of the deleted area, some patients harbor a CBR. CI - Copyright(c) 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. FAU - Dambruoso, Irene AU - Dambruoso I AD - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy i.dambruoso@smatteo.pv.it. FAU - Invernizzi, Rosangela AU - Invernizzi R AD - Division of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. FAU - Boni, Marina AU - Boni M AD - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. FAU - Zappatore, Rita AU - Zappatore R AD - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. FAU - Giardini, Ilaria AU - Giardini I AD - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. FAU - Cavigliano, Maria Paola AU - Cavigliano MP AD - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. FAU - Rocca, Barbara AU - Rocca B AD - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. FAU - Calvello, Celeste AU - Calvello C AD - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. FAU - Bastia, Raffaella AU - Bastia R AD - Division of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. FAU - Caresana, Marilena AU - Caresana M AD - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. FAU - Pasi, Francesca AU - Pasi F AD - Division of Radiotherapy, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. AD - Laboratory of Neuro Radio Experimental Biology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy. FAU - Nano, Rosanna AU - Nano R AD - Laboratory of Neuro Radio Experimental Biology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy. FAU - Bernasconi, Paolo AU - Bernasconi P AD - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. LA - eng PT - Journal Article PL - Greece TA - Anticancer Res JT - Anticancer research JID - 8102988 SB - IM MH - Acute Disease MH - Adult MH - Aged MH - *Chromosome Breakpoints MH - *Chromosome Deletion MH - Chromosomes, Human, Pair 11/*genetics MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Karyotyping MH - Leukemia, Myeloid/*genetics MH - Male MH - Middle Aged MH - Myelodysplastic Syndromes/*genetics OTO - NOTNLM OT - FISH OT - MDS/AML OT - chromosome 11 OT - del(11)(q13-14) OT - deletion OT - morphology EDAT- 2017/02/10 06:00 MHDA- 2017/02/28 06:00 CRDT- 2017/02/10 06:00 PHST- 2016/11/23 00:00 [received] PHST- 2016/12/23 00:00 [revised] PHST- 2017/01/09 00:00 [accepted] PHST- 2017/02/10 06:00 [entrez] PHST- 2017/02/10 06:00 [pubmed] PHST- 2017/02/28 06:00 [medline] AID - 37/2/645 [pii] AID - 10.21873/anticanres.11359 [doi] PST - ppublish SO - Anticancer Res. 2017 Feb;37(2):645-649. doi: 10.21873/anticanres.11359.